1. Garnett ES, Parsons V, Veall N. Measurement of glomerular filtration-rate in man using a 51Cr-edetic-acid complex. Lancet. 1967;1:818–9.
2. Taylor DM, Brock M, Frier M, Joshi VK, Jewkes R, Keeling DH, Hughes D, Little WA, Smith PH, Trott NG, Watson IA, Whately TL, Wood EJ. Guidelines for the preparation of radiopharmaceuticals in hospitals. London: British Institute of Radiology; 1975.
3. Ell PJ, Jarritt PH, Cullum I, Hocknell JM, Costa DC, Lui D, Jewkes RF, Steiner TJ, Nowotnik DP, Pickett RD, et al. Regular cerebral blood flow mapping with 99mTc-labelled compound. Lancet. 1985;2:50–1.
4. Sharp PF, Smith FW, Gemmell HG, Lyall D, Evans NT, Gvozdanovic D, Davidson J, Tyrrell DA, Pickett RD, Neirinckx RD. Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. J Nucl Med. 1986;27:171–7.
5. Higley B, Smith FW, Smith T, Gemmell HG, Das Gupta P, Gvozdanovic DV, Graham D, Hinge D, Davidson J, Lahiri A. Technetium-99m-1,2-bis[bis(2-ethoxyethyl)-phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med. 1993;34:30–8.